NeoCardium Ltd – A New Service Facilitates Regenerative Cardiology Drug Development

A new super specialty regenerative cardiology service launched to support successful clinical development of novel treatments for heart conditions that can be benefited by promoting growth of new tissue to replace, supplement or revascularize the non-functional or under-functioning myocardium. - September 25, 2008

Serendipity Discovers the Holy Grail of Regenerative Cardiology releases a breakthrough research report that solves regenerative cardiology companies’ unyielding problem of translating positive pre-clinical data into successful human trials. - September 17, 2008

Press Releases 1 - 2 of 2